摘要
目的总结SAR1B基因变异致乳糜微粒滞留病(CMRD)的基因型与临床特点。方法病例系列研究,总结2022年5月至2023年7月复旦大学附属儿科医院与江西省儿童医院诊治的2例CMRD患儿的临床资料与基因检测结果。分别以“乳糜微粒滞留病”“乳糜微粒潴留病”“乳糜微粒保留病”“安德森病”“安德森综合征”“chylomicron retention disease”“Anderson syndrome”“Anderson disease”为检索词在中国知网、万方、维普、中国生物医学文献、PubMed数据库自建库至2024年1月进行检索。总结SAR1B基因变异致CMRD的主要临床表现及遗传学特点。结果2例患儿分别为1例11岁男童与1例4月龄女童。2例患儿均有脂质吸收不良、生长不良、胆固醇下降、转氨酶与肌酸激酶升高、维生素E缺乏,基因检查发现分别为SAR1B基因纯合变异(c.224A>G)和复合杂合变异(c.224A>G和c.554G>T)。例1随访1个月余,仍偶有下肢肌痛;例2随访1年余,生长已追赶至正常水平,2例患儿均无其他明显不适。文献复习符合检索条件中文文献0篇,英文文献22篇,包括本研究2例共有51例患者。51例CMRD患者中存在21种SAR1B基因变异,包含10种错义变异,4种无义变异,3种移码变异,框内缺失、剪接位点变异、大片段缺失与大片段缺失插入各1种。51例CMRD患者中,脂质吸收不良49例(腹泻或脂肪泻43例、呕吐17例、腹胀12例)、脂溶性维生素缺乏45例(维生素E缺乏43例、维生素A缺乏10例、维生素D缺乏9例、维生素K缺乏5例),生长不良35例,肝脏受累32例(转氨酶升高32例、脂肪肝5例、肝肿大3例),内镜下可见白色小肠黏膜29例,肌酸激酶升高17例,神经病变14例,眼部病变5例,棘形红细胞增多2例,心脏射血分数降低1例,无症状1例。结论CMRD常表现为婴儿早期脂质吸收不良和生长不良。实验室检测特点为低胆固醇血症,伴或不伴脂溶性维生素缺乏、肝酶和(或)肌酸激酶升高。SAR1B基因型以纯合型为主,错义变异多见。
Objective To summarize the genotype and clinical characteristics of chylomicron retention disease(CMRD)caused by secretion associated Ras related GTPase 1B(SAR1B)gene variations.Methods Clinical data and genetic testing results of 2 children with CMRD treated at Children′s Hospital of Fudan University and Jiangxi Provincial Children′s Hospital from May 2022 to July 2023 were summarized.To provide an overview of the clinical and genetic characteristics of CMRD caused by SAR1B gene variations,all of the literature was searched and reviewed from China National Knowledge Infrastructure,Wanfang Data Knowledge Service Platform,China VIP database,China Biology Medicine disc and PubMed database(up to January 2024)with"chylomicron retention disease""Anderson disease"or"Anderson syndrome"as the search terms.All relevant literatures were reviewed to summarize the clinical and genetic features of CMRD caused by SAR1B gene variations.Results One 11-year-old boy and one 4-month-old girl with CMRD.Both patients had lipid malabsorption,failure to thrive,decreased cholesterol,elevated transaminase and creatine kinase,and Vitamin E deficiency,with homozygous variations(c.224A>G)and compound heterozygous variations(c.224A>G and c.554G>T)in SAR1B gene,respectively.Case 1 was followed up for over a month,and he still occasionally experienced lower limb muscle pain.Case 2 was followed up for more than a year,and her had caught up to normal levels.Both patients had no other significant discomfort.Literature search retrieved 0 Chinese literature and 22 English literatures.In addition to the 2 cases reported in this study,a total of 51 patients were identified as CMRD caused by SAR1B gene variations.Twenty-one types of SAR1B variants 10 missense,4 nonsense,3 frameshift,1 in-frame deletion,1 splice,1 gross deletion,and 1 gross insertion-deletion were found among the 51 CMRD cases.Among all the patients,49 cases had lipid malabsorption(43 cases had diarrhea or fatty diarrhea,17 cases had vomiting,and 12 cases had abdominal distension),45 cases had lipid soluble Vitamin deficiency(43 cases had Vitamin E deficiency,10 cases had Vitamin A deficiency,9 case had Vitamin D deficiency,and 5 cases had Vitamin K deficiency),35 cases had failure to thrive,32 cases had liver involvement(32 cases had elevated transaminases,5 cases had fatty liver,and 3 cases had hepatomegaly),29 cases had white small intestinal mucosa under endoscopy,and 17 cases had elevated creatine kinase,14 cases had neuropathy,5 cases had ocular lesions,2 cases had acanthocytosis,1 case had decreased cardiac ejection fraction,and 1 case was symptom-free.Conclusions Early infancy failure to thrive and lipid malabsorption are common issues for CMRD patients.The laboratory tests are characterized by hypocholesterolemia with or without fat-soluble Vitamin deficiency,elevated liver enzymes and(or)creatine kinase.Currently,missense variations are frequent among the primarily homozygous SAR1B genotypes that have been described.
作者
张宜琼
伍俐亭
成业
陆怡
李玉川
冯佳燕
邢清和
李维君
王建设
Zhang Yiqiong;Wu Liting;Cheng Ye;Lu Yi;Li Yuchuan;Feng Jiayan;Xing Qinghe;Li Weijun;Wang Jianshe(Center for Pediatric Liver Diseases,Children′s Hospital of Fudan University,Shanghai 201102,China;Department of Clinic Nutrition,Jiangxi Provincial Children′s Hospital,Nanchang 330038,China;Department of Pathology,Children′s Hospital of Fudan University,Shanghai 201102,China;Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China)
出处
《中华儿科杂志》
CAS
CSCD
北大核心
2024年第6期565-570,共6页
Chinese Journal of Pediatrics
基金
国家重点研发计划(2021YFC2700800)
复旦大学附属儿科医院重点发展项目(EK2022ZX05)。